IP Library Granted Patent US 8,410,130
Granted Patent B2
US 8,410,130 · App. 12/267,227 · Granted Apr 2, 2013

Synthesis of 8H-3A-aza-cyclopenta [A ]indenes and 5,10-dihydropyrrolo[1,2-B]isoquinolines derivatives and their use as antitumor therapeutic agents

Inventors: Tsann-Long Su (Xizhi, TW); Ting-Chao Chou (Paramus, NJ)
Assignee: Academia Sinica
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,410,130
App. No.
12/267,227
Granted
Apr 2, 2013
Kind
B2
Abstract

The present disclosure relates to a series of bis(hydroxymethyl) and its bis(carbamate) of 8H-3a-azacyclopenta[a]indene-1-yl and 5,10-dihydropyrrolo-[1,2-b]isoquinolines derivatives (Formula I-Formula IV) as DNA di-alkylating agents. The preliminary antitumor studies indicated that compounds disclosed herein could exhibit potent cytotoxicity in vitro and antitumor therapeutic efficacy in human tumor xenografts and could have little or no cross-resistance to either Taxol or Vinblastine. The results demonstrated that compounds disclosed herein possess potent antitumor therapeutic efficacy and are expected to have potential for clinical applications.

Claims (145)

1. A compound of formula I, II, III, or IV:

and pharmaceutically acceptable salts and mixtures thereof,

wherein:

R 1 is chosen from hydrogen, a C 1 -C 5 linear or branched alkyl group, an aryl, and a benzyl, which may be unsubstituted or substituted;

R 2 , R 3 , R 4 and R 5 are independently chosen from hydrogen, C 1 -C 6 alkyl, OR a , halo, cyano, nitro, NH 2 , NHR b , and N(R b ) 2 , wherein R a is chosen from hydrogen and C 1 -C 10 alkyl, and R b is chosen from hydrogen and C 1 -C 10 alkyl; and

R 6 is chosen from a saturated or unsaturated, linear or branched, C 1 -C 5 alkyl group, an unsubstituted or substituted phenyl group, and an unsubstitued or substituted benzyl group,

and further wherein: when the C 1 -C 5 linear or branched alkyl group is substituted, one or more substituents are independently chosen from halogen, hydroxy, alkoxy, lower alkyl, lower alkenyl, and lower alkynyl; and

when the aryl, the benzyl, or the phenyl group is substituted, one or more substituents are independently chosen from C 1 -C 6 alkyl, OR a , halo, cyano, nitro, NH 2 , wherein R a is as defined above.

2. The compound of formula I according to claim 1 , wherein R 2 ═R 3 ═R 5 ═H.

3. The compound of formula II according to claim 1 , wherein R 2 ═R 3 ═R 5 ═H.

4. The compound of formula III according to claim 1 , wherein R 2 ═R 3 ═R 4 ═R 5 ═H.

5. The compound of formula IV according to claim 1 , wherein R 2 ═R 3 ═R 4 ═R 5 ═H.

6. The compound according to claim 1 , wherein the compound is chosen from:

(2-Hydroxymethyl-3-methyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-Ethyl-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-propyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-isopropyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-butyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-phenyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-(2-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-(4-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(3,4-Dimethoxyphenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(2,6-Dimethoxyphenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-(3,4,5-trimethoxyphenyl)-8H-3-aza-cyclopenta[a]inden-1-yl)-methanol;

(2-Hydroxymethyl-3-(4-methylphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-(4-nitrophenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(4-Aminophenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(4-Flourophenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(4-Chlorophenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(3,4-Diflourophenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-yl)methanol;

(3-(3,4-Dichlorophenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-6-methoxy-3-(4-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol,

(2-Hydroxymethyl-6-nitro-3-(4-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)-methanol;

(6-Amino-2-hydroxymethyl-3-(4-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-6-methyl-3-(4-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)-methanol;

(6-Chloro-2-hydroxymethyl-3-methyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(6-Flouro-2-hydroxymethyl-3-methyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(5,6-dimethoxy-2-hydroxymethyl-3-(2-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-hydroxymethyl-4,5,6-trimethoxy-3-methyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(6-dimethylamino-2-hydroxymethyl-3-methyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

Methylcarbamic acid 3-methyl-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta-[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-ethyl-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta-[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-propyl-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-butyl-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-isopropyl-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl-methyl ester;

Methylcarbamic acid 2-methylcarbamoyloxymethyl-3-phenyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethylester;

Methylcarbamic acid 3-(4-flourophenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(4-chlorophenyl)-2-methyl-carbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(3,4-difluorophenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(4-methoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-azacyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(2-methoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(3,4-dimethoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(2,6-dimethoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(3,4,5-trimethoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 6-methoxy-3-(4-methoxyphenyl)-2-methylcarbamoyloxy-methyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(4-methoxyphenyl)-2-methylcarbamoyloxymethyl-6-pyrrolidin-1-yl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(4-methoxyphenyl)-2-methylcarbamoyloxymethyl-6-piperidin-1-yl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(4-nitrophenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(4-aminophenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 5,6-methylenedioxy-2-methylcarbamoyloxymethyl-3-(2-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 5,6-ethylenedioxy-2-methylcarbamoyloxymethyl-3-(2-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Ethylcarbamic acid 2-ethylcarbamoyloxymethyl-3-(4-methoxy-phenyl)-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester:

Propylcarbamic acid 3-methyl-2-propylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Isopropylcarbamic acid 2-isopropylcarbamoyloxymethyl-3-methyl-8H-3a-aza-cyclopenta[a]inden-2-ylmethyl ester;

Isobutylcarbamic acid 2-isobutylcarbamoyloxymethyl-3-methyl-8H-3a-aza-cyclopenta[a]inden-2-ylmethyl ester;

Phenylcarbamic acid 3-methyl-2-phenylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

(1-Hydroxymethyl-3-methyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)methanol;

(3-Ethyl-1-hydroxymethyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)methanol;

(1-Hydroxymethyl-3-phenyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)methanol;

(3-(4-chlorophenyl)-1-hydroxymethyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)-methanol;

[3-(4-fluorophenyl)-1-hydroxymethyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl]-methanol;

[3-(3,4-difluorophenyl)-1-hydroxymethyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl]-methanol;

(1-Hydroxymethyl-3-(2-methoxyphenyl)-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)methanol;

(1-Hydroxymethyl-3-(4-methoxyphenyl)-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)methanol;

[3-(3,4-dimethoxyphenyl)-1-hydroxymethyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl]methanol;

Methylcarbamic acid 3-methyl-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo-[1,2-b]isoquinolin-1-ylmethyl ester;

Methylcarbamic acid 3-ethyl-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo-[1,2-b]isoquinolin-1-ylmethyl ester;

Methylcarbamic acid 2-methylcarbamoyloxymethyl-3-phenyl-5,10-dihydropyrrolo-[1,2-b]isoquinolin-1-ylmethyl ester;

Methyl-carbamic acid 3-(4-chlorophenyl)-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Methylcarbamic acid 3-(4-fluorophenyl)-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Methylcarbamic acid 3-(3,4-diflourophenyl)-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Methylcarbamic acid 3-(2-methoxyphenyl)-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Methylcarbamic acid 3-(4-methoxyphenyl)-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Methylcarbamic acid 3-(3,4-dimethoxyphenyl)-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Propylcarbamic acid 3-methyl-2-propylcarbamoyloxymethyl-5,10-dihydropyrrolo-[1,2-b]isoquinolin-1-ylmethyl ester;

Propylcarbamic acid 3-ethyl-2-propylcarbamoyloxymethyl-5,10-dihydropyrrolo-[1,2-b]isoquinolin-1-ylmethyl ester;

Propylcarbamic acid 3-phenyl-2-propylcarbamoylmethyl-5,10-dihydropyrrolo-[1,2-b]isoquinolin-1-ylmethyl ester;

Propylethylcarbamic acid 3-(4-chlorophenyl)-2-propylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Propylcarbamic acid 3-(4-fluorophenyl)-2-propylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Propylcarbamic acid 3-(3,4-diflourophenyl)-2-propylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Propylcarbamic acid 3-(4-methoxyphenyl)-2-propylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester; and

Propylcarbamic acid 3-(3,4-dimethoxyphenyl)-2-propylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester.

7. The compound according to claim 1 , wherein the compound is chosen from:

(2-Hydroxymethyl-3-methyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-Ethyl-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-phenyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-(2-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-(4-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(3,4-Dimethoxyphenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(2,6-Dimethoxyphenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-3-(3,4,5-trimethoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)-methanol;

(3-(4-Fluorophenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(4-Chlorophenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(3-(3,4-Difluorophenyl)-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

(2-Hydroxymethyl-6-methoxy-3-(4-methoxyphenyl)-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol;

Methylcarbamic acid 3-methyl-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta-[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-ethyl-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta-[a]inden-1-ylmethyl ester;

Methyl-carbamic acid 2-methylcarbamoyloxymethyl-3-phenyl-8H-3a-aza-cyclo-penta[a]inden-1-ylmethylester;

Methylcarbamic acid 3-(4-fluorophenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(4-chlorophenyl)-2-methyl-carbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(3,4-difluorophenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(4-methoxy-phenyl)-2-methylcarbamoyloxymethyl-8H-3a-azacyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(2-methoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(3,4-dimethoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(2,6-dimethoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(3,4,5-trimethoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 6-methoxy-3-(4-methoxyphenyl)-2-methylcarbamoyloxy-methyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester;

(1-Hydroxymethyl-3-methyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)methanol;

(3-(4-chlorophenyl)-1-hydroxymethyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)-methanol;

[3-(3,4-difluorophenyl)-1-hydroxymethyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl]-methanol;

(1-Hydroxymethyl-3-(4-methoxyphenyl)-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)methanol;

Methylcarbamic acid 3-methyl-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo-[1,2-b]isoquinolin-1-ylmethyl ester;

Methyl-carbamic acid 3-(4-chlorophenyl)-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

Methylcarbamic acid 3-(3,4-difluorophenyl)-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester;

and

Methylcarbamic acid 3-(4-methoxyphenyl)-2-methylcarbamoyloxymethyl-5,10-dihydropyrrolo[1,2-b]isoquinolin-1-ylmethyl ester.

8. A pharmaceutical composition comprising the compound of claim 1 and at least one pharmaceutically acceptable excipient.

9. The compound according to claim 1 , wherein the compound is chosen from:

(2-Hydroxymethyl-3-methyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol; and

(3-Ethyl-2-hydroxymethyl-8H-3a-aza-cyclopenta[a]inden-1-yl)methanol.

10. The compound according to claim 1 wherein the compound is:

Methylcarbamic acid 3-(4-methoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-azacyclopenta[a]inden-1-ylmethyl ester;

Methylcarbamic acid 3-(2-methoxyphenyl)-2-methylcarbamoyloxymethyl-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester; and

Ethylcarbamic acid 2-ethylcarbamoyloxymethyl-3-(4-methoxy-phenyl)-8H-3a-aza-cyclopenta[a]inden-1-ylmethyl ester.

11. The compound according to claim 1 , wherein the compound is (1-Hydroxymethyl-3-methyl-5,10-dihydro-pyrrolo[1,2-b]isoquinolin-2-yl)methanol.

12. The pharmaceutical composition according to claim 8 , wherein the compound is chosen from the compounds of claims 9 , 10 , and 11 .

13. The compound according to claim 1 , wherein R 2 , R 3 , R 4 and R 5 are independently chosen from hydrogen and methoxy.

14. A method of inhibiting cancer cell growth, comprising administering an effective amount of the compound of claim 13 to a mammal in need thereof, wherein the cancer is chosen from lung cancer, bladder cancer, colon cancer, prostate cancer, breast cancer, ovarian cancer, oral cancer, leukemia, brain cancer, vinblastine-resistant cancer, and taxol-resistant cancer.

15. A method of killing cancer cells comprising providing an effective amount of the compound of claim 13 to cancer cells, wherein the cancer is chosen from lung cancer, bladder cancer, colon cancer, prostate cancer, breast cancer, ovarian cancer, oral cancer, leukemia, brain cancer, vinblastine-resistant cancer, and taxol-resistant cancer.

16. A method of treating cancer, comprising administering an effective amount of the compound of claim 13 to a mammal in need thereof, wherein the cancer is chosen from lung cancer, bladder cancer, colon cancer, prostate cancer, breast cancer, ovarian cancer, oral cancer, leukemia, brain cancer, vinblastine-resistant cancer, and taxol-resistant cancer.

17. The method according to claim 16 , wherein the compound is chosen from the compounds of claim 6 .

18. The method according to claim 16 , wherein the compound is chosen from the compounds of claim 7 .

19. The method of claim 16 wherein the compound is administered in combination with another form of therapy.

20. The method of dam 16 , wherein the compound is administered in conjunction with radiation therapy, immunotherapy, monoclonal antibody therapy, hormonal therapy, chemotherapy using other agents, and/or surgery.

21. The method of treating cancer according to claim 16 , wherein the compound is chosen from the compounds of claims 9 , 10 , and 11 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2015
From: ACADEMIA SINICA
To: MEMORIAL SLOAN KETTERING CANCER CENTER
Reel/Frame 035522/0583 →
Continuity (2)
Provisional Application 60996241 · Nov 7, 2007
Related Publication 20090117125A1 · May 7, 2009